Cullinan Therapeutics Inc.
CGEM | NASDAQ
$21.35
+$0.27 (+1.28%)
At close: Sep 21, 2026, 4:00 PM ET
$21.35
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.94M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 77K | 76K | 77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -77K | -76K | -77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.94M |
Operating Income | -57.25M | -53.7M | -55.26M | -55.6M | -75.8M | -55M | -55.05M | -48.86M | -50.03M | -42.99M | -45.49M | -45.24M | -37.61M | -62.76M | -32.61M | -29.77M | 239.68M | -32.66M | -34.35M | -18.38M | -16.6M | 1.37M |
Interest Income | 3.65M | 4.1M | 4.62M | 5.09M | 5.92M | 6.58M | 7.51M | 8.38M | 8.07M | 5.69M | 5.92M | 5.88M | 5.32M | 4.51M | 3.36M | 2.35M | 697K | 197K | 137K | 118K | 173K | 49K |
Pretax Income | -53.7M | -49.66M | -50.71M | -50.61M | -70.06M | -48.5M | -47.53M | -40.56M | -42.03M | -37.34M | -39.69M | -39.18M | -32.21M | -58.14M | -28.95M | -27.41M | 240.14M | -32.46M | -34.21M | -18.26M | -16.44M | 1.42M |
Net Income | -53.7M | -49.66M | -50.71M | -50.61M | -70.06M | -48.5M | -47.65M | -40.56M | -42.03M | -37.15M | -23.8M | -39.18M | -32.21M | -57.96M | -26.78M | -24.8M | 174.9M | -12.1M | -32.51M | -17.35M | -15.64M | -70K |
Selling & General & Admin | 12.82M | 11.57M | 12.31M | 13.63M | 14.77M | 13.54M | 14.56M | 13.35M | 13.69M | 12.27M | 10.56M | 10.98M | 10.21M | 10.66M | 11.29M | 10.09M | 10.7M | 8.12M | 13.47M | 5.7M | 4.83M | 5.16M |
Research & Development | 44.44M | 42.12M | 42.95M | 41.97M | 61.03M | 41.46M | 40.49M | 35.51M | 36.26M | 30.65M | 34.85M | 33.82M | 27.39M | 52.1M | 21.32M | 19.68M | 26.41M | 24.54M | 20.88M | 12.68M | 11.78M | 12.42M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 440K | n/a | n/a | n/a | n/a | -276.79M | n/a | n/a | n/a | n/a | -2K |
Operating Expenses | 57.25M | 53.7M | 55.26M | 55.6M | 75.8M | 55M | 55.05M | 48.86M | 49.95M | 42.91M | 45.41M | 45.24M | 37.61M | 62.76M | 32.61M | 29.77M | -239.68M | 32.66M | 34.35M | 18.38M | 16.6M | 17.57M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -77K | -76K | -77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 57.25M | 53.7M | 55.26M | 55.6M | 75.8M | 55M | 55.05M | 48.86M | 50.03M | 42.99M | 45.49M | 45.24M | 37.61M | 62.76M | 32.61M | 29.77M | -239.68M | 32.66M | 34.35M | 18.38M | 16.6M | 17.57M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 117K | n/a | n/a | n/a | -14.12M | n/a | n/a | n/a | -1.86M | -2.52M | 66.07M | -19.57M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 61.49M | 59.2M | 59.2M | 59.02M | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M | 40.68M | 45.75M | 45.61M | 44.87M | 44.43M | 43.52M | 43.44M | 43.3M | 41.98M |
Shares Outstanding (Diluted) | 61.49M | 59.2M | 59.2M | 59.02M | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M | 40.68M | 45.75M | 45.61M | 46.38M | 44.43M | 43.64M | 43.44M | 43.3M | 41.98M |
EPS (Basic) | -0.81 | -0.84 | -0.86 | -0.86 | -1.19 | -0.82 | -0.81 | -0.70 | -0.76 | -0.86 | -0.56 | -0.92 | -0.81 | -1.42 | -0.59 | -0.54 | 3.90 | -0.27 | -0.74 | -0.40 | -0.36 | 0 |
EPS (Diluted) | -0.81 | -0.84 | -0.86 | -0.86 | -1.19 | -0.82 | -0.81 | -0.70 | -0.76 | -0.86 | -0.56 | -0.92 | -0.81 | -1.42 | -0.59 | -0.54 | 3.77 | -0.27 | -0.74 | -0.40 | -0.36 | 0 |
EBITDA | -53.63M | -53.62M | -50.63M | -50.53M | -69.98M | -48.43M | -47.45M | -40.48M | -41.95M | -37.26M | -39.61M | -44.72M | -32.13M | -58.07M | -28.89M | -27.4M | -37.09M | -32.45M | -34.19M | -18.25M | -16.43M | 1.39M |
EBIT | -53.7M | -53.7M | -50.71M | -50.61M | -70.06M | -48.5M | -47.53M | -40.56M | -42.03M | -37.34M | -39.69M | -44.8M | -32.21M | -58.14M | -28.95M | -27.41M | -37.11M | -32.46M | -34.21M | -18.26M | -16.44M | 1.37M |
Depreciation & Amortization | 79K | 79K | 79K | 79K | 77K | 76K | 77K | 76K | 77K | 76K | 77K | 80K | 81K | 72K | 59K | 9K | 12K | 13K | 12K | 13K | 13K | 15K |
Add to Watchlist
Select watchlists to add or remove CGEM